Strainsforpains Stock

Strainsforpains ROE

The Return on Equity (ROE) of Strainsforpains (EBYH) as of Aug 16, 2026 is 13.93 %. In the previous year, Return on Equity (ROE) was 3.12 % — a change of 347.08% (higher).

ROE

13.93 %

YoY

347.08%

Last updated:

In 2026, Strainsforpains's return on equity (ROE) was 13.93 %, a 347.08% increase from the 3.12 % ROE in the previous year.

Access this data via the Eulerpool API

Strainsforpains Stock analysis

What does Strainsforpains do? Strainsforpains Inc - A Story of Pain Relief and Healing Strainsforpains Inc was founded in 2010 by a team of experienced doctors, scientists, and cannabis enthusiasts. The idea behind the company was to provide people with alternative and effective solutions for pain and illnesses that had not been well treated with conventional medications. The business model of Strainsforpains Inc has always been based on the use of medical marijuana, which can provide significant relief and healing for numerous conditions such as chronic pain, depression, epilepsy, and nausea. The company focused on comprehensive research and scientific studies to develop and breed the best marijuana strains for various medical applications. Strainsforpains Inc operates several divisions that cater to the different needs of patients and customers. The main division is the sale of medical marijuana for people with conditions such as cancer, chronic pain, and uncontrollable tremors. The company works with licensed marijuana breeders and growers to produce a wide range of strains suitable for different applications and preferences. Another division of Strainsforpains Inc is the production of medical marijuana products available in various forms such as oils, tinctures, capsules, and lozenges. These products are made from high-quality, pure marijuana extract and are intended for people who do not prefer smoking or vaporizing cannabis flowers or for whom smoking is not appropriate. In recent years, Strainsforpains Inc has also launched a division for recreational marijuana, targeting people who consume marijuana for recreational purposes. The company offers a wide range of strains and products and aims to upgrade the recreational marijuana market by offering healthy and high-quality products. However, the company has not only found success in the medical industry but also in the beauty industry. Strainsforpains Inc has its own division for hemp products that are integrated into the company's skincare products. Hemp oil is rich in antioxidants, anti-inflammatory properties, and moisturizing properties. The products from Strainsforpains Inc are ideal for people who want to fight skin problems such as acne or psoriasis. In conclusion, Strainsforpains Inc is an innovative company that quickly established itself in the market with its focus on alternative medicine and hemp products, helping many people in their healing process. With its comprehensive range of different marijuana strains and products and its focus on medical applications and alternative therapies, the company has provided many patients and customers with a chance for healing and pain relief. Strainsforpains is one of the most popular companies on Eulerpool.

ROE Details

Decoding Strainsforpains's Return on Equity (ROE)

Strainsforpains's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Strainsforpains's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Strainsforpains's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Strainsforpains’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Strainsforpains stock

Return on Equity (ROE) of Strainsforpains is 13.93 % in 2026.

Return on Equity (ROE) of Strainsforpains changed from 3.12 % to 13.93 %, representing a 347.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Strainsforpains since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Strainsforpains with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Strainsforpains

All Key Metrics — Strainsforpains